Respiratory dysfunction in sleep apnea associated with quetiapine

Pharmacopsychiatry

Volumn 41, Issue 3, 2008, Pages 119-121

  Freudenmann, R W ^a   Sussmuth S D ^a   Wolf, R C ^a   Stiller, P ^a   Schonfeldt Lecuona C ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM CARBONATE; LORAZEPAM; MIRTAZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADULT; AGITATION; ARTICLE; CASE REPORT; DISORIENTATION; DRUG WITHDRAWAL; DYSPNEA; EXTUBATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR DEPRESSION; MALE; MANIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP APNEA SYNDROME; SYMPTOMATOLOGY;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATION; SLEEP APNEA SYNDROMES;

EID: 44849129540     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1058111     Document Type: Article

References (15)

1. Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: a case series. Ann Emerg Med 2003; 42: 751-758
2. Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie, 6th edn. Berlin: Springer 2006; 307-309, 362-364
3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259
4. Fernandes PP, Macil WA. Death associated with quetiapine overdose. Am J Psychiatry 2002; 159: 2114
5. Hustey FM. Acute quetiapine poisoning. J Emerg Med 1999; 17: 995-997
6. Jabeen S, Pollo SI, Gerber DR. Acute respiratory failure with a single dose of quetiapine fumarate. Ann Pharmacother 2006; 40: 559-563
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
8. Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther 2000; 68: 92-97
9. Shelton PS, Barnett FL, Krick SE. Hyperventilation associated with quetiapine. Ann Phatmacother 2000; 34: 335-337
10. Stahl SM. Essential psychopharmacology: the prescriber's guide. Cambridge: Cambridge University Press 2006
11. Stephan PL, Jaquenoud Sirot E, Mueller B, Eap CB, Baumann P. Adverse drug reactions following nonresponse in a depressed patient with CYP 2D6 deficiency and low CYP 3A4/5 activity. Pharmacopsychiatry 2006; 39: 150-152
12. Strachan PM, Bernoff BA. Mental status change, myoclonus, electrocardiographic change, and acute respiratory distress syndrome induced by quetiapine overdose. Pharmacotherapy 2006; 26: 578-582
13. The European Agency for the Evaluation of Medicinal Products. (European Medicines Agency E. ICH Topic E 2 A: Clinical safety data management: Definitions and standards for expedited reporting. CPMP/ICH/377/95. 1995
14. Twaites BR, Wilton LV, Shakir SA. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England. J Psychopharmacol 2007; 21: 392-399
15. World Health Organization (WHO). Uppsala Monitoring Centre-Definitions. http://who-umc.org/defs.html